Between 40% and 60% of Americans use complementary and alternative medicine to manage medical conditions, prevent disease, and promote health and well-being. Omega-3 polyunsaturated fatty acids (x-3 PUFAs) have been used to treat joint pain associated with several inflammatory conditions. We conducted a meta-analysis of 17 randomized, controlled trials assessing the pain relieving effects of x-3 PUFAs in patients with rheumatoid arthritis or joint pain secondary to inflammatory bowel disease and dysmenorrhea. Meta-analysis was conducted with Cochrane Review Manager 4.2.8. for six separate outcomes using standardized mean differences (SMDs) as a measure of effect size: (1) patient assessed pain, (2) physician assessed pain, (3) duration of morning stiffness, (4) number of painful and/or tender joints, (5) Ritchie articular index, and (6) nonselective nonsteroidal anti-inflammatory drug consumption. Supplementation with x-3 PUFAs for 3-4 months reduces patient reported joint pain intensity (SMD: À0.26; 95% CI: À0.49 to À0.03, p = 0.03), minutes of morning stiffness (SMD: À0.43; 95% CI: À0.72 to À0.15, p = 0.003), number of painful and/or tender joints (SMD: À0.29; 95% CI: À0.48 to À0.10, p = 0.003), and NSAID consumption (SMD: À0.40; 95% CI: À0.72 to À 0.08, p = 0.01). Significant effects were not detected for physician assessed pain (SMD: À0.14; 95% CI: À0.49 to 0.22, p = 0.45) or Ritchie articular index (SMD: 0.15; 95% CI: À 0.19 to 0.49, p = 0.40) at 3-4 months. The results suggest that x-3 PUFAs are an attractive adjunctive treatment for joint pain associated with rheumatoid arthritis, inflammatory bowel disease, and dysmenorrhea. Ó
Introduction
Between 40% and 60% of Americans use complementary and alternative medicine to manage medical conditions, prevent disease, and promote health and well-being (Astin, 1998; Barnes et al., 2004) . Not surprisingly, 33% of those who use complementary medicine cite pain as the primary reason (Barnes et al., 2004) . Dietary constituents and supplements used as potential therapeutic agents for the treatment of pain include dietary soy, omega-3 polyunsaturated fatty acids (x-3 PUFAs), sucrose, and anthocyanins found in tart cherries and other fruits and vegetables with highly colored pigments (Tall and Raja, 2004) . With one exception, there is little in the way of empirical evidence to support the safe and effective use of dietary supplements for managing pain. The exception is the x-3 PUFAs; controlled trials demonstrate their efficacy in reducing joint pain associated with inflammatory conditions, including rheumatoid arthritis (RA), inflammatory bowel disease, and dysmenorrhea. 
